Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

WGS

GeneDx (WGS)

GeneDx Holdings Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:WGS
DateTimeSourceHeadlineSymbolCompany
30/04/202406:05GlobeNewswire Inc.GeneDx Reports First Quarter 2024 Financial Results and Business HighlightsNASDAQ:WGSGeneDx Holdings Corporation
23/04/202422:30GlobeNewswire Inc.GeneDx Announces Partnership with Komodo Health to Expand Access to World’s Largest Rare Disease DatasetNASDAQ:WGSGeneDx Holdings Corporation
05/04/202407:05GlobeNewswire Inc.GeneDx to Report First Quarter 2024 Financial Results on Monday, April 29, 2024NASDAQ:WGSGeneDx Holdings Corporation
14/03/202423:30GlobeNewswire Inc.GeneDx to Present Data at the 2024 American College of Medical Genetics (ACMG) Annual Meeting Demonstrating Clinical Superiority of its Exome, Paving the Way for the Future of GenomicsNASDAQ:WGSGeneDx Holdings Corporation
06/03/202408:33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:WGSGeneDx Holdings Corporation
27/02/202408:05GlobeNewswire Inc.GeneDx to Participate in 44th Annual Cowen Health Care ConferenceNASDAQ:WGSGeneDx Holdings Corporation
24/02/202408:56Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:WGSGeneDx Holdings Corporation
21/02/202408:28Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:WGSGeneDx Holdings Corporation
21/02/202408:26GlobeNewswire Inc.GeneDx Reports Fourth Quarter and Full Year 2023 Financial Results and Issues Guidance for Full Year 2024NASDAQ:WGSGeneDx Holdings Corporation
02/02/202408:30GlobeNewswire Inc.GeneDx to Report Fourth Quarter 2023 Financial Results on Tuesday, February 20, 2024 NASDAQ:WGSGeneDx Holdings Corporation
25/01/202408:30GlobeNewswire Inc.GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:WGSGeneDx Holdings Corporation
24/01/202408:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:WGSGeneDx Holdings Corporation
09/01/202400:58Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:WGSGeneDx Holdings Corporation
09/01/202400:55GlobeNewswire Inc.GeneDx Announces Preliminary 2023 Financial ResultsNASDAQ:WGSGeneDx Holdings Corporation
05/01/202409:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:WGSGeneDx Holdings Corporation
04/01/202408:25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:WGSGeneDx Holdings Corporation
20/12/202313:25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:WGSGeneDx Holdings Corporation
20/12/202313:24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:WGSGeneDx Holdings Corporation
13/12/202308:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:WGSGeneDx Holdings Corporation
13/12/202308:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:WGSGeneDx Holdings Corporation
06/12/202308:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:WGSGeneDx Holdings Corporation
02/12/202300:30GlobeNewswire Inc.GeneDx Presents New Data at the American Epilepsy Society Annual Meeting Demonstrating That Exome Sequencing Outperforms Multi-Gene Panels for Patients with EpilepsyNASDAQ:WGSGeneDx Holdings Corporation
29/11/202308:05GlobeNewswire Inc.GeneDx to Participate in 6th Annual Evercore ISI HealthCONx ConferenceNASDAQ:WGSGeneDx Holdings Corporation
21/11/202308:05GlobeNewswire Inc.GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:WGSGeneDx Holdings Corporation
18/11/202308:15Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:WGSGeneDx Holdings Corporation
04/11/202307:06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:WGSGeneDx Holdings Corporation
31/10/202307:33Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:WGSGeneDx Holdings Corporation
31/10/202307:05GlobeNewswire Inc.GeneDx Reports Third Quarter 2023 Financial Results and Business HighlightsNASDAQ:WGSGeneDx Holdings Corporation
24/10/202308:52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:WGSGeneDx Holdings Corporation
10/10/202307:05GlobeNewswire Inc.GeneDx to Report Third Quarter 2023 Financial Results on Monday, October 30, 2023NASDAQ:WGSGeneDx Holdings Corporation
 Showing the most relevant articles for your search:NASDAQ:WGS